image

The best stocks to buy since 1993

Latest issue now available

Supreme - Well set for an EPS beat this year

August 2026

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SUP
  • Price:
  • 140p
Full-year numbers are respectable enough on the surface: top-line sales climbed 17% to £270.2m, while EBITDA held its ground at a record £40.6m. EPS slipped to 18.9p, though this is a consequence of tax and accounting adjustments. But the operational drama at Supreme over the coming months will continue to play out in its vaping division.  Dig into that vaping division itself and you find a 15% growth spurt to £148.1m so it would seem Supreme has managed to side step the worst of the UK disposable vape ban by swiftly pivoting towards reusable pod systems - a neat bit of footwork that preserved its vital shelf space across the major supermarket chains. Naturally, this forced transition pinched group gross margins, dragging them dow ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe